UK specialty drugmaker Martindale Pharma has signed a new distribution agreement with Saudi Arabian partner Musaed El Seif Saudi Pharmaceutical Co as part of its new international expansion strategy.
Martindale Pharma already has a scientific office in Saudi Arabia and expects to see sales in the Middle East grow significantly in the next two years.
The agreement with what is one of Saudi Arabia’s leading health care providers will support further growth of Martindale Pharma’s emergency care and hospital-initiated medicines product range in the country.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze